Article: United States : Recombinant Data Corp. Implements Visionary Translational Research Solution for UMass Medical School.

Byline: Mamta03

Recombinant Data Corp., a healthcare data warehousing and clinical intelligence solutions provider, today announced that it has implemented a translational research solution at the University of Massachusetts Medical School.

The project, known as the Massachusetts Integrated Clinical Academic Research Database (MICARD), includes i2b2, an open source technology funded by the National Institutes of Health (NIH). i2b2 provides an Institutional Review Board (IRB)-compliant environment for managing and analyzing clinical data for population-based research, genomic research, clinical trials, and the development of new interventions and ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!